Walleye Trading LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 229 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$5,734,000
-35.9%
61,700
-58.9%
0.02%
-40.6%
Q3 2021$8,939,000
+443.7%
150,100
+522.8%
0.03%
+433.3%
Q2 2021$1,644,000
-59.9%
24,100
-59.2%
0.01%
-68.4%
Q1 2021$4,098,000
+79.6%
59,062
+98.9%
0.02%
+90.0%
Q4 2020$2,282,000
+377.4%
29,700
+364.1%
0.01%
+400.0%
Q3 2020$478,000
+124.4%
6,400
+36.2%
0.00%0.0%
Q4 2019$213,000
-36.6%
4,700
-35.9%
0.00%
-33.3%
Q3 2019$336,000
+52.7%
7,333
+96.1%
0.00%
+50.0%
Q2 2019$220,000
-46.6%
3,740
-59.3%
0.00%
-33.3%
Q1 2019$412,000
-20.8%
9,200
-31.0%
0.00%0.0%
Q4 2018$520,00013,3360.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 505,670$34,487,0007.23%
Asymmetry Capital Management, L.P. 142,246$9,701,0006.67%
Prosight Management, LP 137,000$9,343,0005.84%
Avoro Capital Advisors LLC 4,075,000$277,915,0004.84%
Integral Health Asset Management, LLC 225,000$15,345,0004.22%
First Light Asset Management, LLC 617,124$42,088,0002.52%
SECTORAL ASSET MANAGEMENT INC 322,599$22,001,0001.78%
Avidity Partners Management LP 943,000$64,313,0001.74%
DAFNA Capital Management LLC 119,615$8,158,0001.71%
Nicholas Investment Partners, LP 298,247$20,340,0001.28%
View complete list of ARENA PHARMACEUTICALS INC shareholders